Tessera Therapeutics
George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT), and a core faculty member of the Wyss Institute.
Dr. Church is a pioneer of genome engineering, systems and synthetic biology. He has co-founded more than 14 biotech companies, has authored over 400 papers, and holds 60 patents in his name. He is the Principal Investigator of the Center for Genomically Engineered Organs (CGEO), the Harvard/MIT DOE Genomes-to-Life Center, the Lipper Center for Computational Genetics, and is a founding core member of the Wyss Institute for Biologically Inspired Engineering.
Dr. Church was elected to the National Academy of Sciences (2011) and Engineering (2012), and the Franklin Institute’s Bower Award for Achievement in Science (2011). He holds a Ph.D. in Biochemistry and Molecular Biology from Harvard University.
This person is not in the org chart
This person is not in any offices
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.